tolerogenic dendritic cell therapy (Hospital Clinic of Barcelona/Fundacio Clinic)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametolerogenic dendritic cell therapy (Hospital Clinic of Barcelona/Fundacio Clinic)
Drug Alias NameCrohns disease cell therapy (Hospital Clinic of Barcelona/Fundacio Clinic)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuromyelitis OpticaMultiple SclerosisCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHospital Clinic Of Barcelona (Es)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFundacio Clinic Per A La Recerca BiomedicaHospital Clinic Of Barcelona (Es)
Active IndicationsN/A
Inactive IndicationsNeuromyelitis OpticaMultiple SclerosisCrohn Disease

Other Information

ATC CodeN/A
Related LinksN/A